Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
My American Story
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
My American Story
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Sinovac Biotech Ltd.
< Previous
1
2
Next >
Sinovac Confirms Receipt of an Unsolicited Partial Tender Offer
August 29, 2023
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
Sinovac Announces Change of Legal Representative of Sinovac Beijing
August 28, 2023
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Reports Unaudited First Half of 2023 Financial Results
August 15, 2023
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC’s CoronaVac® Answers Hong Kong’s Need for Self-Pay COVID-19 Vaccines
May 10, 2023
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Reports Unaudited Second Half of 2022 Financial Results and Files 2022 Annual Report on Form 20-F
May 01, 2023
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
Sinovac Amends Shareholder Rights Plan
February 22, 2023
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Reports Unaudited First Half of 2022 Financial Results
December 29, 2022
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Varicella Vaccine Prequalified by WHO
November 03, 2022
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC to Showcase Products at CPHI Frankfurt
October 28, 2022
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Approved to Initiate Clinical Trial for Its Omicron Containing COVID-19 Vaccine in Chile
September 06, 2022
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC COVID-19 Vaccine Approved for Use in Children Above 6 months of Age in Hong Kong
August 03, 2022
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Initiates Clinical Trial for Its Quadrivalent Influenza Vaccine in Chile
July 19, 2022
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC COVID-19 Vaccine Is Authorized for Emergency Use in Kids Aged 3-5 In Brazil
July 14, 2022
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC joins hands with HKU-CTC research team and Gleneagles Hospital Hong Kong to kick off a clinical trial of an Omicron-specific inactivated vaccine for booster use in Hong Kong, China
July 04, 2022
From
SINOVAC Biotech Ltd.
Via
Business Wire
SINOVAC COVID-19 Vaccine Is Conditionally Registered In South Africa
June 25, 2022
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Polio Vaccine Prequalified by WHO
June 08, 2022
From
SINOVAC Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Updates the Status Under Holding Foreign Companies Accountable Act
May 06, 2022
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Reports Unaudited Second Half of 2021 Financial Results and Files 2021 Annual Report on Form 20-F
April 29, 2022
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
Sinovac Amends Shareholder Rights Plan
February 22, 2022
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Reports Unaudited First Half of 2021 Financial Results
December 30, 2021
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
Antigua Court of Appeal Rules in Favor of SINOVAC, Upholds 2018 Judgment
December 09, 2021
From
SINOVAC Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Beijing Settled Litigation of Its Business License and Seals
December 03, 2021
From
SINOVAC Biotech Ltd.
Via
Business Wire
Tickers
SVA
Preliminary Results Show SINOVAC’s COVID-19 Vaccine Demonstrates Good Safety Profile Among the Pediatric and Adolescent Population
November 09, 2021
From
SINOVAC Biotech Ltd.
Via
Business Wire
Tickers
SVA
New Research on SINOVAC’s COVID-19 Vaccine Shows Third Dose More Effective Against COVID-19, Including the Delta Variant
September 09, 2021
From
SINOVAC Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Announces COVID-19 Vaccine Approved for Emergency Use in Chile for Children and Adolescents
September 08, 2021
From
SINOVAC Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Announces Positive Data on Booster Shots of CoronaVac®, Induces Strong Immune Response in Adult and Elderly Populations
August 10, 2021
From
SINOVAC Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Receives Approval on Sabin Strain Based Inactivated Polio Vaccine (sIPV) to Support Global Polio Endgame Strategy
July 19, 2021
From
SINOVAC Biotech Ltd.
Via
Business Wire
Tickers
SVA
SINOVAC Enters Into Agreement to Supply CoronaVac® to COVAX
July 12, 2021
From
SINOVAC Biotech Ltd.
Via
Business Wire
Tickers
SVA
The Lancet Infectious Diseases Published Data from Sinovac’s Phase I/II Study, World’s First Published Study on Clinical Trial Results of a COVID-19 Vaccine in Healthy Children and Adolescents Aged 3 to 17 Years Old
June 30, 2021
From
Sinovac Biotech Ltd.
Via
Business Wire
Tickers
SVA
World Health Organization Authorizes SINOVAC’s CoronaVac® for Emergency Use
June 02, 2021
From
SINOVAC Biotech Ltd.
Via
Business Wire
Tickers
SVA
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at
/week.
Subscribe Today